Indivior (GB:INDV) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Indivior PLC is actively engaging with Oaktree Capital Management to explore proposals aimed at enhancing shareholder value. The Board is committed to maintaining shareholders’ best interests as it continues to implement its strategic objectives. Indivior, a pharmaceutical company, is dedicated to developing treatments for substance use disorders and expanding its global reach.
For further insights into GB:INDV stock, check out TipRanks’ Stock Analysis page.

